MedPath

Comparison of Pregabalin and Sodium Valproate on prophylaxis of migraine type headache

Not Applicable
Conditions
Migraine.
Migraine
Registration Number
IRCT2012070310178N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

all patients with diagnosis of migraine based on International Headache Society criteria.
Exclusion criteria: other types of headache; administration of prophylactic treatment for migraine; pregnancy; breast feeding; sensitivity to Pregabalin or Sodium Valproate.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of migraine type headaches. Timepoint: entrance to study, 1, 2 and 3 months after intervention. Method of measurement: history taking and patient's notes.;Intensity of migraine headaches. Timepoint: entrance to study, 1, 2 and 3 months after intervention. Method of measurement: Wong-Baker Faces Pain Rating Scale.
Secondary Outcome Measures
NameTimeMethod
Consumption of analgesics. Timepoint: entrance to the study, 1, 2 and 3 months after intervention. Method of measurement: history taking and patient's notes.
© Copyright 2025. All Rights Reserved by MedPath